ClinicalTrials.Veeva

Menu

Effect of Myoma Removal on Blood Pressure and Erythropoetin Level

S

Shiraz University of Medical Sciences

Status

Completed

Conditions

Hypertension
Myoma

Treatments

Procedure: myoma removal

Study type

Interventional

Funder types

Other

Identifiers

NCT00898170
88-2505

Details and patient eligibility

About

The effect of myoma removal was studied on 28 patients with hypertension and myoma by holter monitoring and erythropoetin level check.

Full description

Background:

Myoma is the most common gynecoid tumor and produces many vasoactive substances, which may be a cause for secondary hypertension. Early reports suggested the association of myoma and hypertension. We studied the effect of myoma removal on hypertension and erythropoietin level to evaluate this hypothesis.

Patients & Methods:

In this single centered prospective cohort study, in twenty eight patients who were candidates for myomectomy due to myoma, 24 hour holter monitoring of blood pressure and serum erythropoietin were checked before and 6 weeks after hysterectomy.

Enrollment

28 patients

Sex

Female

Ages

22 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • candidate for myoma removal by hysterectomy
  • operable
  • hysterectomy is indicated

Exclusion criteria

  • patient refusal
  • inoperable patients
  • other secondary cases of hypertension

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Quadruple Blind

28 participants in 1 patient group

myoma, with or without hypertension
Experimental group
Description:
those with myoma with or without hypertension in holter monitoring
Treatment:
Procedure: myoma removal

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems